3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Fallopian Tube Neoplasms
1
Interventions
Paclitaxel
20
Carboplatin
16
liposomal doxorubicin
10
Bevacizumab
10
Gemcitabine
8
Topotecan
7
Taxes
7
Cisplatin
7
pembrolizumab
6
Doxorubicin
5
Cyclophosphamide
5
Nivolumab
4
fludarabine
3
Oxaliplatin
3
Immunoglobulin G
3
Hyperthermic Intraperitoneal Chemotherapy
3
Disulfides
3
Cytoreduction Surgical Procedures
3
trebananib
2
talazoparib
2
rucaparib
2
peginterferon alfa-2b
2
olaparib
2
fludarabine phosphate
2
aldesleukin
2
Surgical Procedures, Operative
2
STA 9090
2
Platinum
2
Lenalidomide
2
Irinotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Fallopian Tube Neoplasms
×
demcizumab
×
Clear all
NCT01952249
2020-09-09
SIERRA
Mereo BioPharma
Phase 1
Terminated
20 enrolled